Drugline is a fortnightly electronic drug bulletin for health professionals.
Scroll

Drugline

Drugline is a fortnightly electronic drug bulletin providing information on new medicines, new developments, current affairs, new indications, new PBS listings and deletions and general issues of importance to all health professionals. Click below to view the most recent volumes of Drugline.

Neuromuscular Blocking Agents

Drugline Volume 355

The Therapeutic Goods Administration (TGA) has introduced new warnings for neuromuscular blocking agents (NMBA). NMBAs available in Australia are atracurium, cisatracurium, mivacurium, pancuronium, rocuronium, vecuronium, and suxamethonium. These medications are considered high-risk as unintentional…

Read more

Pembrolizumab Listing Extended

Drugline Volume 354

From 1st November 2018, pembrolizumab is available on the Pharmaceutical Benefits Scheme (PBS) for the first-line treatment of metastatic non-small cell lung cancer. This is in addition to its original listing for Stage III…

Read more

New Hope for Cystic Fibrosis

Drugline Volume 353

From the 1st October 2018, lumacaftor and ivacaftor (Orkambi®) became available on the Pharmaceutical Benefits Scheme (PBS). This combination tablet is approved for use in patients over six years of age who are homozygous…

Read more

The Black Triangle Scheme

Drugline Volume 352

Before a medication is registered for use in Australia, comprehensive data must be submitted to the Therapeutic Goods Administration (TGA) to support its quality, safety, and efficacy. However, this data typically only comes from…

Read more

Reporting of Medicine Shortages

Drugline Volume 351

The Therapeutic Goods Amendment (2018 Measures No. 1) Bill 2018 has passed the Senate and will come into effect on 1st January 2019. The main focus of this bill concerns the communication of medicine…

Read more

Appropriate use of slow-release opioids

Drugline Volume 350

The Australian and New Zealand College of Anaesthetists (ANZCA) has released a position statement recommending that slow-release opioids should not be used for the management of acute pain. For the purposes of this discussion,…

Read more
Load More

November 2018

October 2018

September 2018

August 2018

July 2018

April 2018

January 2018

December 2017

September 2017

Thunderstorm Asthma (Sep. 21 2017)

The Efficacy of Perampanel (Sep. 08 2017)

July 2017

June 2017

April 2017

March 2017

November 2016

September 2016

August 2016

April 2016

November 2015

Viekira Pak for Hepatitis C (Nov. 19 2015)

Micafungin (Nov. 05 2015)

October 2015

Dabigatran Antidote on the Horizon (Oct. 22 2015)

Akynzeo® (Oct. 08 2015)

September 2015

May 2015

April 2015

Victoza (liraglutide) (Apr. 23 2015)

Ultibro Breezhaler 100/50 (Apr. 09 2015)

March 2015

February 2015

December 2014

November 2014

October 2014

September 2014

World Pharmacist Day (Sep. 24 2014)

National Stroke Week (Sep. 11 2014)

August 2014

July 2014

Breo™ Ellipta® (Jul. 31 2014)

Use of Prolia® in Men (Jul. 17 2014)

Adcetris® (brentuximab vedotin) (Jul. 03 2014)

April 2014

March 2014

September 2013

August 2013

July 2013

June 2013

Riluzole for Motor Neurone Disease (Jun. 20 2013)

Mycamine (Jun. 06 2013)

May 2013

HPV Vaccine (May. 23 2013)

World Lupus Day (May. 09 2013)

December 2012

November 2012

August 2012